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Aim: Chronic obstructive pulmonary disease (COPD) is highly prevalent and results in significant health, 
economic and social burden. In Portugal, the number of patients diagnosed with COPD has increased 241%, 
between 2011 and 20161. Thus, the assessment of patients with COPD is becoming an essential part of 
today’s routine clinical practice. However, there are few studies characterising Portuguese patients with 
COPD to support health professionals’ interpretation of clinical assessments and enable comparisons with 
other populations. This study aimed to characterise Portuguese patients with COPD with commonly used 
clinical measures.  
Method: A cross-sectional study was conducted. Patients with COPD were recruited from routine 
pulmonology appointments and primary care centres of Portugal. Assessments included a spirometric test, 
the modified Medical Research Council dyspnoea questionnaire (mMRC), the COPD Assessment Test, the 
Saint George Respiratory Questionnaire, the Hospital Anxiety and Depression Scale, quadriceps muscle 
strength, with handheld dynamometer; handgrip strength, with hydraulic hand dynamometer; maximal 
inspiratory/expiratory pressures; the 5-times sit-to-stand test and the 1-minute sit-to-stand test. Descriptive 
statistics were used to characterize the sample. 
Results: 327 patients were enrolled (252 males; 66.7±10.2years; FEV1 60.5±25.1% predicted). Most patients 
were at GOLD grade 2 (n=132; 40%), followed by grade 3 (n=90; 28%), 1 (n=73; 22%) and 4 (n=32; 10%). 
Considering the ABCD assessment tool defined by symptoms (mMRC) and number of exacerbations, 
patients were mostly from group A (n=129; 39%), followed by groups B (n=95; 29%), D (n=69; 21%) and C 
(n=34; 10%). Table 1 presents the values obtained for each outcome measure per gender. 
Conclusion: This is the first study presenting a general characterisation of Portuguese patients with COPD. 
Such values will inform health professionals’ interpretation of clinical assessments. Future studies should 
explore differences and provide reference values across the ABCD groups. 
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